Objectives of the CRT meeting
- Focus on implementing Guidelines at the national level, involving National Cardiac Societies (NCS) together with other national stakeholders. This includes national health authorities, non-cardiological societies, allied professionals and suitable patient's associations.
- Understand the pathways to improve implementation of ESC guidelines, using two recent ESC guidelines as working models, one in the acute setting and another in chronic primary and secondary prevention settings. Specifically, this will involve the implementation of the 2023 ESC Guidelines on Acute Coronary Syndrome (ACS) and 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. The aim is to map out the journey from their release to their practical application by May 2025, using experience in both in-hospital and outpatient settings.
- Identify weaknesses, address challenges and propose/hypothesize solutions to common obstacles at the national level in selected countries as ‘example’.
- Present successful guidelines implementation paths in some countries.
- Conclude the meeting by drafting a blueprint that could serve as a proposal for the NCS & ESC on implementing Guidelines, involving representatives from national cardiological and potentially related non-cardiological societies. A checkpoint could be planned in 6-8 months, with the final aim being to set up a working agenda for the next 4 to 5 years.
Session Recordings
Co-Chairs
Academic Chairpersons
- Prof. Robert Byrne
- Prof. Bianca Rocca
- Prof. Cecilia Linde (ESC President-elect and ESC Chair of the CRT)
Industry Chairpersons
- Dr. Sanjay Gandhi (Philips)
- Dr. Bettina Kraus (Boehringer-Ingelheim)
- Dr. Ola Vedin (Astra Zeneca)
- Prof. Alexandra Goncalves /BMS (Industry Chair of the CRT)
Day 1: 2 July 2025 13:00–18:20 CEST
|
Time and Session |
Speakers |
|
13:00-13:10- Welcome from the CRT Chairpersons |
|
|
13:10-13:25- Chairpersons Perspective: How we arrived at this meeting and what we want to achieve |
|
|
13:25-14:20- SESSION 1.1: Learning by Example Part 1- Examples of Implementation in ACS MODERATED BY: Robert Robert Byrne and Ola Vedin (AstraZeneca) |
|
|
13:25-13:40- EUROHEART: a tool to analyze ACS treatment across Europe and harmonize strategies |
Stefan James |
|
13:40-13:55- How ACVC specialists can implement the ESC 2023 ACS Guidelines |
Kurt Huber |
|
13:55-14:10- Optimization of the ESC 2024 ACS guidelines after hospital discharge: the Swedish experience |
Matthias Lidin |
|
14:10-14:30- PANEL DISCUSSION |
|
|
14:30-14:40- Short Break |
|
|
14:40 -18:20 SESSION 1.2 – Learning by Example Part 2: New tools and strategies to successfully implement Guidelines in different settings Moderated by: Bianca Rocca and Sanjay Gandhi (Philips) |
|
|
14:40-14:55 The ESC Chatbot: a tool for Guidelines implementation |
|
|
14:55-15:10 Guidelines implementation: frameworks in relation to resource settings |
|
|
15:10-15:25 How patient versions of Guidelines can support implementation? |
(ESC Patient Forum & Clinical Practice Guidelines member) |
|
15:25-15:40 PANEL DISCUSSION |
|
|
15:40-16:10 Coffee Break |
|
|
16:10-17:10- BREAKOUT SESSIONS: Applying Learnings from these Examples: what works well strategies and solutions preparing tomorrow’s breakout |
|
|
Group 1: Implementation of the ESC 2023 ACS guidelines: Strategies to adapt across national resource settings and, the contribution of the national societies. |
Lead: Felix Mahfoud Rapporteur: Friedric Fuchs (Siemens-Healthineers) |
|
Group 2: ESC Guidelines implementation via joint decision-making: Specialty and patient versions, to enhance mutual understanding. |
Lead: Katja Rohwedder (Bayer) Rapporteur: Tomas Lapinskas |
|
Group 3: ESC Guidelines implementation in the real-world setting: How data, clinical paths and technological tools support clinicians and patients. |
Lead: Ruxandra-Maria Christodorescu Rapporteur: Valerie Gossye (J&J Innovative Medicine) |
|
17:15-17:25 Report from breakout session 1 |
Rapporteur: Friedric Fuchs (Siemens-Healthineers) |
|
17:25-17:35 Report from breakout session 2 |
Rapporteur: Tomas Lapinskas |
|
17:35-17:45 Report from breakout session 3 |
Rapporteur: Valerie Gossye (J&J Innovative Medicine) |
|
17:45-18:10 PANEL DISCUSSION |
|
|
18:10-18:20 Wrap-up and summary Day 1- Outlook to Day 2 |
Robert Byrne Ola Vedin (AstraZeneca) |
|
END OF DAY 1 |
|
|
19:00 APERITIF + DINNER |
|
Day 2: 3 July 2025 08:30–12:40 CEST
| Time and Session | Speaker | Time and Session | Speaker |
| 8:30-8:40- Summary of day 1, Set-up and Goals for Today |
Robert Byrne & Bettina Kraus (BI) | ||
|
8:45-10:30- Developing paths and blueprints to improve implementation Breakout Groups A and B |
|||
|
BREAKOUT Group B: Developing paths and blueprints to improve implementation of the ESC 2023 ACS guideline |
BREAKOUT Group A: Developing paths and blueprints to improve implementation of the ESC 2024 Hypertension guideline |
||
|
PRESENTATIONS: successful examples of guidelines implementation from National Cardiac Societies (NCS) Moderated by: Bianca Rocca and Sanjay Gandhi (Philips) |
PRESENTATIONS: Implementation Paths by Sub-specialty: What Have You Done and What Do You Plan to Do? Moderated by: Cecilia Linde and Bettina Kraus (Boehringer-Ingelheim) |
||
| 8:45-8:55- Successful examples of the ESC 2023 ACS Guidelines implementation: the experience of the Polish National Cardiological Society | Robert Gil | 8:45-8:55- The experience of the ERA (European Renal Association) on the implementation of the 2024 ESC Guidelines for the management of elevated blood pressure and hypertension | Carmine Zoccali (VIA ZOOM) |
| 8:55-9:05-Successful examples of the ESC 2023 ACS Guidelines implementation: the experience of the ANMCO | Massimo Grimaldi | 8:55-9:05- How does ACNAP foresee the role of specialized nurses in the implementation of 2024 ESC Guidelines for the management of elevated blood pressure and hypertension? | |
| 9:05-9:15- Implementation of guideline recommendation changes: The experience in Denmark | Christian Hassager | 9:05-9:15- The ESC Council on Cardiology Practice for the implementation of 2024 ESC Guidelines for the management of elevated blood pressure and hypertension | Luigina Guasti |
| 9:15-10:30- GROUP DISCUSSION and roadmap development towards creating a draft blueprint for national societies on implementing the ESC 2023 ACS guidelines |
Lead: Kurt Huber Rapporteur: Marek Gierlotka |
9:15-10:30- The ESC Council of Hypertension for the implementation of the 2024 Hypertension Guidelines | Eva Gerdts |
|
|
9:25-10:30- GROUP DISCUSSION and roadmap development towards creating a draft blueprint for national societies on implementing of the ESC 2024 Hypertension guideline |
Lead: Leonie Klompstra Rapporteur: Teresa Glynn (Global Heart Hub) |
|
|
10:30-10:50- Coffee break |
|||
|
Plenary Future Implementation of the ACS and Hypertension guidelines Moderated by : Bianca Rocca and Ola Vedin (AstraZeneca) |
|||
| Time and Session | Speaker |
| 10:50-11:05- Report from breakout group A on ACS | Rapporteur: Marek Gierlotka |
| 11:05-11:35- GROUP DISCUSSION about the roadmap proposal related to the ESC 2023 ACS guidelines |
|
| 11:35-11:50- Report from breakout group B on Hypertension | Rapporteur: Teresa Glynn (Global Heart Hub) |
| 11:50-12:20- GROUP DISCUSSION about the roadmap proposal related to the ESC 2024 Hypertension guideline | |
| 12:20-12:30- NEXT STEPS: Define Checkpoints, working agenda for coming years |
Cecilia Linde and Ola Vedin (AstraZeneca) |
|
12:30-12:40- Wrap-up & conclusion |
|
|
END OF DAY 2 |
|
|
12:45- Buffet lunch and departures |
|
Biographies
- Prof. Cecilia LINDE, Sweden
- Prof. Alexandra GONCALVES, BMS
- Prof. Robert A. BYRNE, Ireland
- Associate Prof. Ruxandra Maria CHRISTODORESCU, Romania
- Dr. Friedrich FUCHS, Siemens Healthineers
- Dr. Sanjay GANDHI, Philips, USA
- Prof. Marek GIERLOTKA, Poland
- Prof. Robert GIL, Poland
- Ms. Teresa GLYNN, Ireland
- Prof. Eva GERDTS, Norway
- Dr. Valerie GOSSYE, J&J Innovative Medicine
-
Prof. Massimo GRIMALDI, Italy
- Prof. Christian HASSAGER, Denmark
- MD, FESC, FACC, FAHA . Kurt HUBER , Austria
- Prof. Stefan JAMES, Sweden
- Assoc. Prof. Leonie KLOMPSTRA, Sweden
- Dr. Bettina KRAUS, Boehringer-Ingelheim
- Prof. Tomas LAPINSKAS, Lithuania
- Dr. Matthias LIDIN R.N, Sweden
- Prof. Felix MAHFOUD, Switzerland
- Ms. Inge Mølgaard, Denmark
- Prof. Eva PRESCOTT, Denmark
- Prof. Bianca ROCCA, Italy
- Dr. Francisco Javier ROSSELLO LOZANO, Spain
- Dr. Ola VEDIN, AstraZeneca
Our mission: To reduce the burden of cardiovascular disease.